WVE Q3 2024 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$8M-115.6% YoY

Gross Profit

-$8M100.0% margin

Operating Income

-$64M832.7% margin

Net Income

-$62M804.8% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

-139.0%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$47M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$359M

Total Liabilities

$209M

Stockholders' Equity

$150M

Cash & Equivalents

$311M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$8M	$49M	-115.6%
Gross Profit	-$8M	$18M	-143.7%
Operating Income	-$64M	$4M	-1538.2%
Net Income	-$62M	$7M	-951.9%